New study shows young donor FMT reduces liver inflammation and tumor incidence in old mice by downregulating MDM2, highlighting gut-liver axis in aging and cancer. New research demonstrates that trans...
New UK Biobank study links PM2.5 and NO2 to accelerated epigenetic aging and brain shrinkage, emphasizing the need for pollution control. Long-term exposure to air pollution may accelerate biological ...
The 2025 longevity investment landscape shifts from narrow anti-aging to a full innovation stack, led by cellular reprogramming, brain longevity diagnostics, and platform infrastructure. Investors pou...
New study reveals distinct immature neuron signatures in resilient Alzheimer’s brains, opening avenues for regenerative therapies. Recent research identifies a unique transcriptional profile in ...
New actigraphy data shows naps over 1 hour are associated with 33% higher mortality and increased Alzheimer’s pathology, but causation remains unclear. Excessive daytime napping may signal under...
A 2025 study on Tibetan herders shows 30% higher inflammatory markers, contrasting with moderate altitude benefits. Implications for aging research and hypoxia-based therapies. High altitude may accel...
A study from C. elegans to humans shows that age-related reduction in phosphatidylcholine synthesis impairs mitochondria, with choline supplementation reversing effects, though more trials needed. A g...
A 2024 JAMA Network Open study finds that napping over 30 minutes daily may raise mortality risk in older adults, but experts urge caution in interpreting the findings. A new study links excessive nap...
A January 2025 Cell Metabolism study reveals obesity induces lasting epigenetic changes in T cells, causing persistent inflammation even after weight loss, challenging current recovery assumptions. Ne...
A new study reveals that dasatinib and quercetin (D+Q) cause demyelination in mice, raising safety concerns as over 30 clinical trials test the combo for age-related diseases. A study in Nature Aging ...
